Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis

Anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may trigger immune-mediated adverse events, including myocarditis. Evidence of vaccine safety in patients with rheumatic disorders and underlying autoimmune myocarditis is scarce. To address this issue, we studied 13 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Giuseppe A., Batani, Veronica, Moroni, Luca, De Luca, Giacomo, Pizzetti, Giuseppe, Sala, Simone, Peretto, Giovanni, Campochiaro, Corrado, Della-Torre, Emanuel, Bozzolo, Enrica P., Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502100/
https://www.ncbi.nlm.nih.gov/pubmed/36145434
http://dx.doi.org/10.3390/pathogens11091001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502100/
https://www.ncbi.nlm.nih.gov/pubmed/36145434
http://dx.doi.org/10.3390/pathogens11091001

Ejemplares similares